BackAmicus Therapeutics Overview
Amicus Therapeutics Inc

Amicus Therapeutics Target Price

Analysts' 12-month price predictions for FOLD.

Share Price

$6.71

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-10-17Bank of America SecuritiesTazeen Ahmad$15123.5% upsideOpen
2024-05-14GuggenheimDebjit Chattopadhyay$1393.7% upsideOpen
2024-05-09Morgan StanleyJeffrey Hung$19183.2% upsideOpen
2023-12-19Morgan StanleyJeffrey Hung$20198.1% upsideOpen
2021-05-10Goldman SachsSalveen Richter$14108.6% upsideOpen